What is Indapta Therapeutics worth?
$90.0Mlast known valuation
Indapta Therapeutics last raised $50.8M in its Later Stage VC (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Indapta Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Later Stage VC | $50.8M | ▮ | ▮ |
| Dec 2024 | Later Stage VC | $22.5M | ▮ | ▮ |
| May 2023 | Later Stage VC (Series A) | $80.0M | ▮ | ▮ |
| Jan 2022 | Early Stage VC | $33.6M | ▮ | ▮ |
How Indapta Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Indapta Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Indapta Therapeutics worth?
- Indapta Therapeutics's last known valuation is $90.0M.
- How much has Indapta Therapeutics raised?
- Indapta Therapeutics has raised $162.3M in total funding across 4 recorded rounds.
- When did Indapta Therapeutics last raise?
- Indapta Therapeutics last raised in Sep 2025 (Later Stage VC), raising $50.8M.